Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/38475
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Theda C. | en |
dc.contributor.author | Lao J.C. | en |
dc.contributor.author | Berger P.J. | en |
dc.contributor.author | Nold M.F. | en |
dc.contributor.author | Nold-Petry C.A. | en |
dc.contributor.author | Bui C.B. | en |
dc.contributor.author | Pang M.A. | en |
dc.contributor.author | Sehgal A. | en |
dc.date.accessioned | 2021-05-14T13:07:41Z | en |
dc.date.available | 2021-05-14T13:07:41Z | en |
dc.date.copyright | 2017 | en |
dc.date.created | 20171019 | en |
dc.date.issued | 2017-10-19 | en |
dc.identifier.citation | Journal of Reproductive Immunology. 124 (pp 21-29), 2017. Date of Publication: November 2017. | en |
dc.identifier.issn | 0165-0378 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/38475 | en |
dc.description.abstract | Bronchopulmonary dysplasia (BPD) and BPD-associated pulmonary hypertension (BPD-PH) are chronic inflammatory cardiopulmonary diseases with devastating short- and long-term consequences for infants born prematurely. The immature lungs of preterm infants are ill-prepared to achieve sufficient gas exchange, thus usually necessitating immediate commencement of respiratory support and oxygen supplementation. These therapies are life-saving, but they exacerbate the tissue damage that is inevitably inflicted on a preterm lung forced to perform gas exchange. Together, air-breathing and necessary therapeutic interventions disrupt normal lung development by aggravating pulmonary inflammation and vascular remodelling, thus frequently precipitating BPD and PH via an incompletely understood pathogenic cascade. BPD and BPD-PH share common risk factors, such as low gestational age at birth, fetal growth restriction and perinatal maternal inflammation; however, these risk factors are not unique to BPD or BPD-PH. Occurring in 17-24% of BPD patients, BPD-PH substantially worsens the morbidity and mortality attributable to BPD alone, thus darkening their outlook; for example, BPD-PH entails a mortality of up to 50%. The absence of a safe and effective therapy for BPD and BPD-PH renders neonatal cardiopulmonary disease an area of urgent unmet medical need. Besides the need to develop new therapeutic strategies, a major challenge for clinicians is the lack of a reliable method for identifying babies at risk of developing BPD and BPD-PH. In addition to discussing current knowledge on pathophysiology, diagnosis and treatment of BPD-PH, we highlight emerging biomarkers that could enable clinicians to predict disease-risk and also optimise treatment of BPD-PH in our tiniest patients.Copyright © 2017 Hudson Institute of Medical Research | en |
dc.language | English | en |
dc.language | en | en |
dc.publisher | Elsevier Ireland Ltd | en |
dc.relation.ispartof | Journal of Reproductive Immunology | en |
dc.title | Pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infants. | en |
dc.type | Review | en |
dc.type.studyortrial | Review article (e.g. literature review, narrative review) | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.jri.2017.09.013 | en |
dc.publisher.place | Ireland | en |
dc.identifier.pubmedid | 29035757 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29035757] | en |
dc.identifier.source | 618722566 | en |
dc.identifier.institution | (Bui, Pang, Lao, Berger, Nold, Nold-Petry) Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia (Bui, Pang, Sehgal, Lao, Berger, Nold, Nold-Petry) Department of Paediatrics, Monash University, Melbourne, Victoria, Australia (Sehgal, Nold) Monash Newborn, Monash Health, Clayton, Victoria, Australia (Theda) The Royal Women's Hospital, Melbourne, Victoria, Australia | en |
dc.description.address | C.A. Nold-Petry, Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia. E-mail: claudia.nold@hudson.org.au | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2018 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Biomarkers Bronchopulmonary dysplasia Predictors Preterm infants Pulmonary hypertension | en |
dc.identifier.authoremail | Nold-Petry C.A.; claudia.nold@hudson.org.au | en |
dc.description.grant | No: CF14/3517 Organization: *National Heart Foundation of Australia* Organization No: 501100001030 Country: Australia | en |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | Review | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
crisitem.author.dept | Paediatric - Neonatal (Monash Newborn) | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.